Fault Line AI
Fault Line AI is an independent research organization providing safety validation, procurement evidence, and runtime monitoring for clinical and wellbeing AI systems. The company uses a data-driven taxonomy of 139 failure modes, condensed into 22 risk dimensions, to generate bespoke testing suites and deploy AI auditing agents that probe systems with thousands of adversarial conversations. It serves healthcare organizations, clinical AI developers, and medical device companies needing independent, regulator-aligned safety evidence.
- Artificial Intelligence
- Regulatory & Compliance Technology
- Healthcare Technology
- AI Agents
- Digital Health
- Software Only
- Data & Analytics
Funding
Founders
Founder details are not available yet.
Product
Problem
Manual red-teaming and testing of clinical AI systems is expensive and creates bottlenecks that slow release cadence. Automated tests are often tokenistic and fail to detect how generative AI actually fails in real-world clinical environments. Healthcare organizations face increasing regulatory pressure to demonstrate pre-deployment proof and post-deployment monitoring before entering the market.
Solution
Fault Line AI provides a full-stack safety layer for clinical AI, covering the entire lifecycle from pre-deployment testing through runtime guardrails and performance monitoring. The platform creates bespoke testing suites rooted in a comprehensive, data-driven taxonomy of 139 failure modes compiled from leading benchmarks, empirical studies, risk registries, and regulatory sources. Purpose-built AI auditing agents probe clinical systems with thousands of adversarial conversations designed to elicit the full spectrum of risks that surface in real clinical use. These agents are built on complex, dynamic scaffolds that enable testing in ways that clinicians, vignettes, and existing automated evals cannot replicate. The platform also provides ongoing runtime guardrails and monitoring to ensure continued safety after deployment. Fault Line positions itself as an independent third-party evaluator, noting that buyers and regulators trust third-party evidence over self-assessment.
Target Audience
Primary customers are healthcare organizations, clinical AI developers, and medical device companies that need to demonstrate safety and regulatory compliance before deploying AI systems in clinical settings.
Features
- Bespoke testing suite generation rooted in a 139-dimension risk taxonomy sourced from AIID, MIT AI Risk Repository, HealthBench, MEDIC, FDA MAUDE, MATRIX, HAICEF, MITRE ATT&CK, ECRI, and RUAIH
- Purpose-built AI auditing agents that run thousands of adversarial conversations to probe for the full spectrum of clinical AI risks
- Dynamic scaffolding that enables testing approaches beyond what clinicians, vignettes, and existing automated evals can achieve
- Runtime guardrails that provide ongoing protection during live clinical deployment
- Performance monitoring capabilities that track system behavior post-deployment
- Comprehensive source integration covering 50+ scientific benchmarks, empirical studies, registries, and regulatory guidance documents
- Data-driven FAULT taxonomy built via factor analysis of 14,232 health-related datasets, condensing failure modes into 22 risk dimensions
- Epidemiological analysis of 132,505 benchmark and real-world conversations to assess risk prevalence and benchmark representativeness